{"id":"https://genegraph.clinicalgenome.org/r/5a36a6ae-9225-477e-ad73-bd77aa4f1be0v1.3","type":"EvidenceStrengthAssertion","dc:description":"KCNQ1 encodes the alpha subunit of the slowly activating delayed rectifier cardiac potassium channel (Iks). Wang et al. were the first to identify variants in this gene using linkage analysis in families with LQTS (PMID 8528244). An abundance of experimental and genetic evidence, including segregation and case-control data, has accumulated over the decades since this publication to support the association of KCNQ1 with LQTS. \nNote: All LQTS genes were curated by 3 separate blinded teams. The evidence and scores reached by these 3 teams were reviewed by the LQTS Clinical Domain Expert Panel. For a detailed discussion of this group's work and the separate scores of the 3 teams please see \"Adler et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020;141(6):418-428. doi: 10.1161/CIRCULATIONAHA.119.043132”","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5a36a6ae-9225-477e-ad73-bd77aa4f1be0","GCISnapshot":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2021-01-14T16:40:37.711Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2018-09-25T04:00:00.000Z","role":"Approver"}],"curationReasonDescription":"Evidence supporting KCNQ1 as causative for LQTS has been replicated over time.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/918a3a0f-fc0b-4c95-809b-536d6fa0beaa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99ae672f-1687-4bad-ab0b-21d02302c986","type":"Finding","dc:description":"Potassium channel dysfunction caused LQTS.  Demonstration of delayed rectifier current in CHO cells that have been cotransfected with KvLQT1 and hminK suggests the coexpression of these two proteins is required for adequate channel function.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8900283","rdfs:label":"K+ current - CHO cells","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4d906b59-6b07-439f-a88e-a5761e521743","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb413c79-b79d-4e60-9a67-c8da53d01688","type":"Finding","dc:description":"The LQTS phenotype is the result of abnormal repolarization caused by ion channel dysfunction.  Therefore demonstration that KvLQT1 is responsible for electrical current in xenopus oocytes supports the role of this gene as the cause for LQTS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9108097","rdfs:label":"Yang 1997 - K+ current measurement","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b275ce1-73ba-43e5-b275-e0ce4afb239a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/768a634d-540e-45dd-8a70-0ba71e13fb61","type":"FunctionalAlteration","dc:description":"6 variants demonstrated statistically significantly decreased K+ currents, compared with WT.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9312006","rdfs:label":"functional outward current"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/35a77c25-756c-4af5-94e4-067e80060254","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbd22f36-dc8c-4151-9201-80ca1eb83214","type":"FunctionalAlteration","dc:description":"Compared WT KvLQT1 currents, mutant KvLQT1 currents, and currents generated by coinjections.\nAll three variants demonstrated reduced current in xenopus oocyte cells compared with WT.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9323054","rdfs:label":"Shalaby - IKs current"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a83bc78a-784f-48b7-bf92-3e17577c3ee4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb18c162-ce20-4762-ac4c-f69bb3178217","type":"FunctionalAlteration","dc:description":"IKs made up from D202H mutants showed smaller currents with a similar activation\ntime course to WT over the physiological range of voltages. The activation time constants did not decrease significantly at more positive potentials,unlike WT (Fig. 3 B), and this was accompanied by a positive shift in the V1/2 of activation of 17 mV from WT. The combination of the positive displacement of the activation relationship and the lower overall expression  resulted in much reduced peak currents in D202H in the physiological\nrange of plateau potentials, 0 and +20 mV. \nThe D202H mutation accelerated the rate of channel deactivation compared with WT.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20421371","rdfs:label":"S3 mutations and channel function"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7febfffc-c232-421b-a664-e9f7e79c0afd","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0547f09-0c2a-47dc-ad57-54270f1f19fa","type":"Finding","dc:description":"A340E\n- heterozygotes demonstrated prolonged QT, prolonged QTc and prolonged JT intervals similar to humans RWS\n- homozygotes demonstrated more profound effects on the above parameters\n\nA340V - showed no prolonged QT in homozygous or heterzygous mice\nT311I\n- heterozygotes showed prolonged QT intervals\n- homozygotes had prevalent cardiac phenotype and mimics JLNS","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15498462","rdfs:label":"Mouse Model - LQTS","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3c6d2496-1c96-4bf7-b822-a891cf360aa5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9491960-9ad5-43da-81f0-f1c05d0f77d1","type":"Finding","dc:description":"At the age of 4–5 months, the positive founders and age- and sex-matched littermates (2 male positive founders and 6 male controls) were characterized phenotypically with a 12-lead surface ECG. The transgenes caused a marked QT prolongation with an abnormal T wave morphology and an altered QT/RR relationship.\nIn transgenic rabbits, the QTpeak and total QT interval were significantly prolonged, with no significant difference in either Tpeak–Tend duration or the RR intervals or QRS\nand PR duration.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18464931","rdfs:label":"Rabbit Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3befece2-a742-48d5-a66a-32f0ce6f3abe","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3befece2-a742-48d5-a66a-32f0ce6f3abe_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19841300","rdfs:label":"Kapa Case-Control 2009","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/4a8e2fe1-0ebf-4b9b-95ec-9c13ae6ceb53","type":"Cohort","allGenotypedSequenced":388,"alleleFrequency":0.288659793814433,"detectionMethod":"Mutation analyses were performed with polymerase chain reaction and either denaturing high-performance liquid chromatography, followed by\nautomated DNA sequencing or direct high-throughput DNA sequencing.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3befece2-a742-48d5-a66a-32f0ce6f3abe_cc_evidence_item"}],"numWithVariant":112,"relatedCondition":{"id":"obo:MONDO_0002442"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/a4631153-d877-4b1d-8f39-fc0123be0562","type":"Cohort","allGenotypedSequenced":1344,"alleleFrequency":0.01041666666666667,"detectionMethod":"Mutation analyses were performed with polymerase chain reaction and either denaturing high-performance liquid chromatography, followed by\nautomated DNA sequencing or direct high-throughput DNA sequencing.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3befece2-a742-48d5-a66a-32f0ce6f3abe_cc_evidence_item"}],"numWithVariant":14},"method":{"id":"cg:AggregateVariantAnalysis"},"pValue":0,"statisticalSignificanceType":"mutations/subject in cases v. controls","statisticalSignificanceValueType":"Other"}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/b0a4967a-2a89-4fbf-9e49-7d20e7f86cf3","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0a4967a-2a89-4fbf-9e49-7d20e7f86cf3_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11216980","rdfs:label":"LQTS Finland-Control Finland","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/900b1a17-204b-4ede-b89f-3260a48536c2","type":"Cohort","allGenotypedSequenced":114,"alleleFrequency":0.2982456140350877,"detectionMethod":"After PCR, the samples were digested with the enzyme HhaI (New England Biolabs, Beverly, Massachusetts), followed by electrophoresis on a 12% polyacrylamide gel. The normal allele is cleaved into two fragments (38 and 26 bp in size), whereas the allele corresponding to the G589D mutation remains uncleaved (64 bp).","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0a4967a-2a89-4fbf-9e49-7d20e7f86cf3_cc_evidence_item"}],"numWithVariant":34,"relatedCondition":{"id":"obo:MONDO_0002442"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/78705b28-c415-45d4-8af5-3df5a9fdd3c2","type":"Cohort","allGenotypedSequenced":200,"alleleFrequency":0,"detectionMethod":"After PCR, the samples were digested with the enzyme HhaI (New England Biolabs, Beverly, Massachusetts), followed by electrophoresis on a 12% polyacrylamide gel. The normal allele is cleaved into two fragments (38 and 26 bp in size), whereas the allele corresponding to the G589D mutation remains uncleaved (64 bp).","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0a4967a-2a89-4fbf-9e49-7d20e7f86cf3_cc_evidence_item"}],"numWithVariant":0},"method":{"id":"cg:SingleVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValueType":""}],"specifiedBy":"GeneValidityCaseControlSingleVariantAnalysisCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6355902-af6d-4f0a-9bc4-a777b80824e3_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10220144","rdfs:label":"2164","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/b6355902-af6d-4f0a-9bc4-a777b80824e3","type":"Family","rdfs:label":"2164","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/299514f1-832f-477b-b35b-5c8fe6c69fb2_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528244","rdfs:label":"K1532","family":{"id":"https://genegraph.clinicalgenome.org/r/299514f1-832f-477b-b35b-5c8fe6c69fb2","type":"Family","rdfs:label":"K1532"},"meetsInclusionCriteria":true,"phenotype":{"id":"obo:HP_0001657"},"phenotypeFreeText":"Long QT syndrome","phenotypePositiveAllelePositive":70,"publishedLodScore":14.19,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a763ae86-bb1a-4406-b1b2-2322c8cfdfcc_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76e768c8-06f1-467d-b005-2bcfeaa339c3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15950200","rdfs:label":"1","firstTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a763ae86-bb1a-4406-b1b2-2322c8cfdfcc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15950200","allele":{"id":"https://genegraph.clinicalgenome.org/r/7067f05e-86ca-4f7a-826c-24bc6f008763","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001148.6(ANK2):c.10901T>A (p.Val3634Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145025"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/950a2769-f02d-409b-b401-9e0a51de42e2_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/debee9b5-6ba8-4cbe-b1dc-0da338b9d565","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17655673","rdfs:label":"1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":10,"detectionMethod":"KCNQ1,KCNH2,SCN5A,KCNJ2,KCNE1 & KCNE2 were sequenced","firstTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/950a2769-f02d-409b-b401-9e0a51de42e2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17655673","allele":{"id":"https://genegraph.clinicalgenome.org/r/3df29c1e-7f29-44fe-b2d0-d7c9cf841174","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000218.3(KCNQ1):c.824_826del (p.Phe275del)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/53112"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c578451-3f2a-45f1-b1b6-160a10ba7f09_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e3acdad-bf2a-428e-a86a-0ba9b05f5b9c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22739119","rdfs:label":"1","firstTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3c578451-3f2a-45f1-b1b6-160a10ba7f09_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22739119","allele":{"id":"https://genegraph.clinicalgenome.org/r/7750e7d1-37ae-4b15-8d60-13888b90afe2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000218.3(KCNQ1):c.1893del (p.Arg632GlufsTer34)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/53026"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/dff8874e-98a1-472b-9cc2-3f441b1c1064_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4fb36a4-cb06-42bc-a6c8-e473e56ff5fe_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Only paternity is confirmed, not maternity.  In addition, limited details about phenotype/diagnosis are included.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8678cdba-d7c9-46d4-8de4-bfbcfb3120db","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8872472","rdfs:label":"SQT08","detectionMethod":"SSCP analysis, using the KVLQT1 PCR primer sets described by Wang et al. (6) was performed","firstTestingMethod":"Genotyping","phenotypeFreeText":"Long QT syndrome","phenotypes":"obo:HP_0001657","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e4fb36a4-cb06-42bc-a6c8-e473e56ff5fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8872472","allele":{"id":"https://genegraph.clinicalgenome.org/r/43359dc3-a7ee-43d2-86b8-450a918a36a5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000218.3(KCNQ1):c.1022C>T (p.Ala341Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA004897"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5bcb7ef6-e7e2-4c2b-bd8f-782e327b4a09_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83ae7566-22fb-4a84-aca4-7a8d35da2e06","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10220144","rdfs:label":"2379","detectionMethod":"The purified PCR products were sequenced with both amplification primers, forward\nand reversed, using the Dye Terminator Cycle sequencing Kit (Perkin Elmer) and analysed on an ABI-377 sequencer. Some fragments were sequenced directly without prior SSCP analysis.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypeFreeText":"Long QT syndrome","phenotypes":"obo:HP_0001657","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5bcb7ef6-e7e2-4c2b-bd8f-782e327b4a09_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10220144","allele":{"id":"https://genegraph.clinicalgenome.org/r/859044cc-92b7-4268-a6ae-9c49afaf74b1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000218.3(KCNQ1):c.944A>C (p.Tyr315Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA008803"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":3.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":1833,"specifiedBy":"GeneValidityCriteria7","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/6g3qulqe88M","type":"GeneValidityProposition","disease":"obo:MONDO_0002442","gene":"hgnc:6294","modeOfInheritance":"obo:HP_0000006"},"version":"1.3","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_dff8874e-98a1-472b-9cc2-3f441b1c1064-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}